Timing Matters in Specialty and Rare Disease Marketing

Modeled Audiences Miss the Moment

But modeled audiences completely miss this.

Modeled audiences are built on consumer and behavioral profiles. Age. Gender. Income. Lifestyle attributes.

Those signals change slowly. Health events do not.

As a result, a model trained on people diagnosed two years ago looks nearly identical to one trained on people diagnosed in the last three months.

The Wrong Tool for Precision Timing

So if your goal is to reach someone at a specific point in their journey, modeled audiences are the wrong tool.

The patient who was diagnosed yesterday and the patient who has been living with their condition for five years look identical in consumer data. Same demographics. Same purchasing patterns. Same lifestyle signals.

But their needs—and the relevance of your message—couldn't be more different.

What Works Instead

Audiences built from actual healthcare data at the group level. Evidence of diagnosis, treatment starts, or symptom history.

With evidence-based audiences, timing can be captured. You can distinguish between patients who have lived with symptoms for years and those encountering them for the first time.

And campaigns perform better when audiences reflect where patients are in their journey.

The Bottom Line

In specialty and rare disease marketing, timing isn't just important—it's everything. The moment of diagnosis, the start of treatment, the first encounter with symptoms: these are the windows when your message matters most.

Modeled audiences can't see those windows. Evidence-based audiences can. And that difference translates directly into campaign performance.